Volume 10, Issue 38 (3-2020)
NCMBJ 2020, 10(38): 51-60 |
Back to browse issues page
Department of Biology, Science Faculty, Islamic Azad University, Shahrekord Branch, Shahrekord, Iran
Abstract: (2444 Views)
Aim and Background: Diabetes mitigates beta cells and impairs their function. Silymarin improves this disorder and decreases and also significantly increases the expression of insulin. The purpose of this study was to evaluate the effect of Silymarin on blood glucose and expression Hnf4a gene is in streptozotocin-diabetic male rats.
Material and methods: In this research, 42 male rats were randomly selected and divided into 7 groups of heparin, diabetic rats with diabetes mellitus and streptozotocin, and their fasting blood glucose was measured. Then, doses of 50, 100, and 150 were given to the Marin's slider recipients.The rats were then anesthetized with medication. A portion of the pancreatic tissue was isolated and used to evaluate the expression of Hnf4a gene using Real Time RT PCR.
Results: Investigating the expression of Hnf4a expression at 150 mg/kg doses in rats receiving silymarin showed that in this dose significant reduction of Hnf4a gene was introduced as an effective dose (P-value <0.05). In the future, silymarin can be considered as a Herbal medicine used to treat diabetes.
Conclusion: By studying the results of this study, it can be said that the silymarin plant has anti-inflammatory effects and can be effective in reducing diabetes mellitus.
Material and methods: In this research, 42 male rats were randomly selected and divided into 7 groups of heparin, diabetic rats with diabetes mellitus and streptozotocin, and their fasting blood glucose was measured. Then, doses of 50, 100, and 150 were given to the Marin's slider recipients.The rats were then anesthetized with medication. A portion of the pancreatic tissue was isolated and used to evaluate the expression of Hnf4a gene using Real Time RT PCR.
Results: Investigating the expression of Hnf4a expression at 150 mg/kg doses in rats receiving silymarin showed that in this dose significant reduction of Hnf4a gene was introduced as an effective dose (P-value <0.05). In the future, silymarin can be considered as a Herbal medicine used to treat diabetes.
Conclusion: By studying the results of this study, it can be said that the silymarin plant has anti-inflammatory effects and can be effective in reducing diabetes mellitus.
Type of Study: Research Article |
Subject:
Cellular and molecular
Received: 2020/05/13 | Accepted: 2020/05/13 | Published: 2020/05/13
Received: 2020/05/13 | Accepted: 2020/05/13 | Published: 2020/05/13
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |